Irritable Bowel Syndrome Treatment Market Size, Share & Report

Irritable Bowel Syndrome Treatment Market (2025 - 2030) Size, Share & Analysis Report By Type (IBS-C, IBS-D), By Product (Xifaxan, Linzess/Constella, Viberzi, Amitiza), By Distribution Channel, By Region, And Segment Forecasts

Market Segmentation

Irritable Bowel Syndrome Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
- IBS-Cs
- IBS-D
Irritable Bowel Syndrome Treatment Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
- Xifaxan
- Linzess/Constella
- Viberzi
- Amitiza
- Others
Irritable Bowel Syndrome Treatment Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
- Hospital Pharmacy
- Retail Pharmacy
- Others
Irritable Bowel Syndrome Treatment Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Irritable Bowel Syndrome Treatment Market, by Type
    - IBS-C
    - IBS-D
  - North America Irritable Bowel Syndrome Treatment Market, by Drug Class
    - Xifaxan
    - Linzess/Constella
    - Viberzi
    - Amitiza
    - Others
  - North America Irritable Bowel Syndrome Treatment Market, by Distribution Channel
    - Hospital Pharmacy
    - Retail Pharmacy
    - Others
  - U.S.
    - U.S. Irritable Bowel Syndrome Treatment Market, by Type
      - IBS-C
      - IBS-D
    - U.S. Irritable Bowel Syndrome Treatment Market, by Drug Class
      - Xifaxan
      - Linzess/Constella
      - Viberzi
      - Amitiza
      - Others
    - U.S. Irritable Bowel Syndrome Treatment Market, by Distribution Channel
      - Hospital Pharmacy
      - Retail Pharmacy
      - Others
  - Canada
    - Canada Irritable Bowel Syndrome Treatment Market, by Type
      - IBS-C
      - IBS-D
    - Canada Irritable Bowel Syndrome Treatment Market, by Drug Class
      - Xifaxan
      - Linzess/Constella
      - Viberzi
      - Amitiza
      - Others
    - Canada Irritable Bowel Syndrome Treatment Market, by Distribution Channel
      - Hospital Pharmacy
      - Retail Pharmacy
      - Others
- Europe
  - Europe Irritable Bowel Syndrome Treatment Market, by Type
    - IBS-C
    - IBS-D
  - Europe Irritable Bowel Syndrome Treatment Market, by Drug Class
    - Xifaxan
    - Linzess/Constella
    - Viberzi
    - Amitiza
    - Others
  - Europe Irritable Bowel Syndrome Treatment Market, by Distribution Channel
    - Hospital Pharmacy
    - Retail Pharmacy
    - Others
  - UK
    - UK Irritable Bowel Syndrome Treatment Market, by Type
      - IBS-C
      - IBS-D
    - UK Irritable Bowel Syndrome Treatment Market, by Drug Class
      - Xifaxan
      - Linzess/Constella
      - Viberzi
      - Amitiza
      - Others
    - UK Irritable Bowel Syndrome Treatment Market, by Distribution Channel
      - Hospital Pharmacy
      - Retail Pharmacy
      - Others
  - Germany
    - Germany Irritable Bowel Syndrome Treatment Market, by Type
      - IBS-C
      - IBS-D
    - Germany Irritable Bowel Syndrome Treatment Market, by Drug Class
      - Xifaxan
      - Linzess/Constella
      - Viberzi
      - Amitiza
      - Others
    - Germany Irritable Bowel Syndrome Treatment Market, by Distribution Channel
      - Hospital Pharmacy
      - Retail Pharmacy
      - Others
  - France
    - France Irritable Bowel Syndrome Treatment Market, by Type
      - IBS-C
      - IBS-D
    - France Irritable Bowel Syndrome Treatment Market, by Drug Class
      - Xifaxan
      - Linzess/Constella
      - Viberzi
      - Amitiza
      - Others
    - France Irritable Bowel Syndrome Treatment Market, by Distribution Channel
      - Hospital Pharmacy
      - Retail Pharmacy
      - Others
  - Italy
    - Italy Irritable Bowel Syndrome Treatment Market, by Type
      - IBS-C
      - IBS-D
    - Italy Irritable Bowel Syndrome Treatment Market, by Drug Class
      - Xifaxan
      - Linzess/Constella
      - Viberzi
      - Amitiza
      - Others
    - Italy Irritable Bowel Syndrome Treatment Market, by Distribution Channel
      - Hospital Pharmacy
      - Retail Pharmacy
      - Others
  - Spain
    - Spain Irritable Bowel Syndrome Treatment Market, by Type
      - IBS-C
      - IBS-D
    - Spain Irritable Bowel Syndrome Treatment Market, by Drug Class
      - Xifaxan
      - Linzess/Constella
      - Viberzi
      - Amitiza
      - Others
    - Spain Irritable Bowel Syndrome Treatment Market, by Distribution Channel
      - Hospital Pharmacy
      - Retail Pharmacy
      - Others
- Asia Pacific
  - Asia Pacific Irritable Bowel Syndrome Treatment Market, by Type
    - IBS-C
    - IBS-D
  - Asia Pacific Irritable Bowel Syndrome Treatment Market, by Drug Class
    - Xifaxan
    - Linzess/Constella
    - Viberzi
    - Amitiza
    - Others
  - Asia Pacific Irritable Bowel Syndrome Treatment Market, by Distribution Channel
    - Hospital Pharmacy
    - Retail Pharmacy
    - Others
  - Japan
    - Japan Irritable Bowel Syndrome Treatment Market, by Type
      - IBS-C
      - IBS-D
    - Japan Irritable Bowel Syndrome Treatment Market, by Drug Class
      - Xifaxan
      - Linzess/Constella
      - Viberzi
      - Amitiza
      - Others
    - Japan Irritable Bowel Syndrome Treatment Market, by Distribution Channel
      - Hospital Pharmacy
      - Retail Pharmacy
      - Others
  - China
    - China Irritable Bowel Syndrome Treatment Market, by Type
      - IBS-C
      - IBS-D
    - China Irritable Bowel Syndrome Treatment Market, by Drug Class
      - Xifaxan
      - Linzess/Constella
      - Viberzi
      - Amitiza
      - Others
    - China Irritable Bowel Syndrome Treatment Market, by Distribution Channel
      - Hospital Pharmacy
      - Retail Pharmacy
      - Others
- Latin America
  - Latin America Irritable Bowel Syndrome Treatment Market, by Type
    - IBS-C
    - IBS-D
  - Latin America Irritable Bowel Syndrome Treatment Market, by Drug Class
    - Xifaxan
    - Linzess/Constella
    - Viberzi
    - Amitiza
    - Others
  - Latin America Irritable Bowel Syndrome Treatment Market, by Distribution Channel
    - Hospital Pharmacy
    - Retail Pharmacy
    - Others
  - Brazil
    - Brazil Irritable Bowel Syndrome Treatment Market, by Type
      - IBS-C
      - IBS-D
    - Brazil Irritable Bowel Syndrome Treatment Market, by Drug Class
      - Xifaxan
      - Linzess/Constella
      - Viberzi
      - Amitiza
      - Others
    - Brazil Irritable Bowel Syndrome Treatment Market, by Distribution Channel
      - Hospital Pharmacy
      - Retail Pharmacy
      - Others
  - Argentina
    - Argentina Irritable Bowel Syndrome Treatment Market, by Type
      - IBS-C
      - IBS-D
    - Argentina Irritable Bowel Syndrome Treatment Market, by Drug Class
      - Xifaxan
      - Linzess/Constella
      - Viberzi
      - Amitiza
      - Others
    - Argentina Irritable Bowel Syndrome Treatment Market, by Distribution Channel
      - Hospital Pharmacy
      - Retail Pharmacy
      - Others
- MEA
  - MEA Irritable Bowel Syndrome Treatment Market, by Type
    - IBS-C
    - IBS-D
  - MEA Irritable Bowel Syndrome Treatment Market, by Drug Class
    - Xifaxan
    - Linzess/Constella
    - Viberzi
    - Amitiza
    - Others
  - MEA Irritable Bowel Syndrome Treatment Market, by Distribution Channel
    - Hospital Pharmacy
    - Retail Pharmacy
    - Others
  - South Africa
    - South Africa Irritable Bowel Syndrome Treatment Market, by Type
      - IBS-C
      - IBS-D
    - South Africa Irritable Bowel Syndrome Treatment Market, by Drug Class
      - Xifaxan
      - Linzess/Constella
      - Viberzi
      - Amitiza
      - Others
    - South Africa Irritable Bowel Syndrome Treatment Market, by Distribution Channel
      - Hospital Pharmacy
      - Retail Pharmacy
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments